首页 | 官方网站   微博 | 高级检索  
     

慢性HBV感染不同状态下HBsAg定量的临床意义
引用本文:曹鸿挺,洪俊强,罗海波,刘运周,胡卫红,徐博宁,杨程.慢性HBV感染不同状态下HBsAg定量的临床意义[J].医学研究杂志,2015,44(4):142-145,155.
作者姓名:曹鸿挺  洪俊强  罗海波  刘运周  胡卫红  徐博宁  杨程
作者单位:510318 广州, 中国人民解放军第421医院检验科;521000 潮州, 中国人民解放军第188医院肿瘤科;510318 广州, 中国人民解放军第421医院检验科;510318 广州, 中国人民解放军第421医院检验科;510318 广州, 中国人民解放军第421医院检验科;510318 广州, 中国人民解放军第421医院检验科;510010 广州, 中国人民解放军广州军区总医院医务科
摘    要:目的 探讨HBsAg定量在慢性HBV感染自然史的不同阶段及HBV相关肝硬化中的临床意义。 方法 纳入慢性HBV感染患者185例,其中无肝硬化患者根据自然史分为免疫耐受组(n=34)、HBeAg阳性慢性乙型肝炎(chronic hepatitis B,CHB)组(n=25)、非活动携带组(n=24)及HBeAg阴性CHB组(n=34),肝硬化患者分为HBeAg阳性组(n=33)及HBeAg阴性组(n=35)。检测患者血清HBsAg、HBV DNA、ALT等指标。 结果 无肝硬化的慢性HBV感染患者HBsAg水平由高到低为:免疫耐受组(4.60±0.32)log10IU/ml)]、HBeAg阳性CHB组(4.36±0.45)log10IU/ml]、非活动携带组(3.51±0.30)log10IU/ml]、HBeAg阴性CHB组(3.62±0.35)log10IU/ml]。无肝硬化患者,年龄与HBsAg水平呈负相关(P=0.000);ALT与HBsAg水平无相关性(P=0.152)。免疫耐受及HBeAg阳性CHB组HBsAg水平与HBV DNA呈正相关(P=0.000,P=0.009)。HBeAg阳性肝硬化患者HBsAg水平(4.27±1.33) log10IU/ml]与HBeAg阴性患者(3.81±1.07) log10IU/ml]相似,HBsAg与年龄及ALT无相关性(P>0.05)。 结论 HBsAg水平在HBeAg阳性患者中可反映HBV DNA复制情况。无论有无肝硬化存在,HBsAg水平都不能反映肝组织炎性情况。

关 键 词:乙型肝炎病毒  乙型肝炎表面抗原  自然史  肝硬化
收稿时间:2014/8/15 0:00:00
修稿时间:2014/9/24 0:00:00

Clinical Implications of HBsAg Quantitation Under Different Conditions of Chronic HBV Infection
Cao Hongting,Hong Junqiang,Luo Haibo.Clinical Implications of HBsAg Quantitation Under Different Conditions of Chronic HBV Infection[J].Journal of Medical Research,2015,44(4):142-145,155.
Authors:Cao Hongting  Hong Junqiang  Luo Haibo
Affiliation:The Clinical Laboratory, 421 Hospital of PLA, Guangdong 510318, China;The Clinical Laboratory, 421 Hospital of PLA, Guangdong 510318, China;The Clinical Laboratory, 421 Hospital of PLA, Guangdong 510318, China;The Clinical Laboratory, 421 Hospital of PLA, Guangdong 510318, China;The Clinical Laboratory, 421 Hospital of PLA, Guangdong 510318, China
Abstract:Objective To investigate the clinical implications of HBsAg quantitation in the natural history of chronic HBV infection and HBV-related cirrhosis. Methods A total of 185 patients with chronic HBV infection were included. Patients without cirrhosis were divided into the immune tolerance group (n=34), HBeAg-positive chronic hepatitis B (chronic hepatitis B, CHB) group (n=25), inactive carrier group (n = 24) and HBeAg-negative CHB group (n=34); patients with cirrhosis were divided to HBeAg-positive (n=33) and HBeAg-negative groups (n=35). We detected serum HBsAg, HBV DNA, ALT and other indicators. Results For patients without cirrhosis, HBsAg levels were (4.60±0.32) log10IU/ml in immune tolerance group, (4.36±0.45) log10IU/ml in HBeAg-positive CHB group, (3.51±0.30) log10IU/ml in the inactive carries group, and (3.62±0.35) log10IU/ml in HBeAg-negative CHB group. For patients without cirrhosis, their age was correlated with HBsAg level (P=0.000), but no correlation existed between ALT and HBsAg (P=0.152). HBsAg levels of immune tolerance and HBeAg-positive CHB groups were correlated with HBV DNA levels (P=0.000,P=0.009). HBsAg levels of HBeAg-positive (4.27±1.33) log10IU/ml and HBeAg-negative (3.81±1.07) log10IU/ml groups were similar in cirrhotic patients, and HBsAg was not correlated with age or ALT (P>0.05). Conclusion HBsAg level in HBeAg-positive patients may reflect HBV DNA replication. In patients with or without cirrhosis, HBsAg can not reflect the inflammation of the liver.
Keywords:Hepatitis B virus  Hepatitis B surface antigen  Natural history  Cirrhosis
点击此处可从《医学研究杂志》浏览原始摘要信息
点击此处可从《医学研究杂志》下载全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司    京ICP备09084417号-23

京公网安备 11010802026262号